Table 1.
Summary of case reports using systemic chemotherapy for cHCC-CC (n = 4)
| Author (year) | Age/gender | Risk factors | Metastasis | Chemotherapy | Result |
|---|---|---|---|---|---|
| Hayashi (2006)26 | 52/M | NA | NA | CDDP, 5-FU, RT | NED (42 mo) |
| Kim (2010)24 | 62/M | NA | Lung, bone | ACà5-FU | SD (18 mo) |
| Tani (2011)27 | 30/M | Hepatitis B | Lung | GEM+CBDCA+5FU | SD (TBD) |
| Chi (current) | 31/F | NA | Lung | GEM+CDDP | SD (12 mo) DOD (41 mo) |
*5-FU, flurouracil; AC, doxorubicin and cisplatin; CBDCA, carboplatin; CDDP, cisplatin; DOD, died of disease; GEM, gemcitabine; NA, not applicable; NED, no evidence of disease; RT, radiation therapy; SD, stable disease; TBD, to be determined.